EMEA-001045-PIP01-10-M01

Key facts

Invented name
Kevzara
Active substance
sarilumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0348/2017
PIP number
EMEA-001045-PIP01-10-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, spondylarthritis, psoriatic arthritis and juvenile idiopathic arthritis)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Sanofi-Aventis Recherche & Développement
Tel. +33 169745695
E-mail: contact-us@sanofi.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating